Ó³»­´«Ã½

Viktor Adalsteinsson is the director of the Gerstner Center for Cancer Diagnostics at the Ó³»­´«Ã½ of MIT and Harvard. He also leads the Blood Biopsy Team, a multi-institutional collaboration to profile cancer genomes directly from blood samples. The Blood Biopsy Team includes scientists, engineers, oncologists, and computational biologists spanning numerous investigators and labs at the Ó³»­´«Ã½, MIT, Dana-Farber Cancer Institute, Massachusetts General Hospital, and others. The goal of their research is to develop impactful new diagnostic methods that stand to benefit millions of cancer patients, such as novel approaches for cancer detection and monitoring using blood biopsies.

Adalsteinsson holds a Ph.D. in chemical engineering from MIT (J. Christopher Love lab), where he developed novel approaches for functional and genomic profiling of single cells in cancer such as circulating tumor cells. He has been an affiliate of the Ó³»­´«Ã½ since 2011, has run his own research lab at the Ó³»­´«Ã½ since 2015, and established the Gerstner Center for Cancer Diagnostics with Todd Golub in 2019. Adalsteinsson has analyzed over 15,000 blood biopsies and contributed to more than 45 publications and 12 patents with 4,000 citations in the fields of cancer genomics, cancer diagnostics, and biotechnology. Adalsteinsson was honored by MIT Technology Review in 2017 as a visionary member of its and by Clinical OMICs in 2021 as one of its Pioneers Under 40.

Contact Viktor Adalsteinsson via email at viktor@broadinstitute.org.